In another study, Pepe et al. evaluated 125 men with clinical parameters at high risk for PCa with mpMRI and 68Ga-PSMA PET-CT; the accuracy of 68Ga PSMA PET-CT (SUVmax cut-off ≥ 8) in diagnosing csPCa(clinically significant prostate cancer) compared to mpMRI (PI-RADS score ≥ 3) was 92% versus 86.2% [15]. The gene discussed is FOLH1; the disease is prostate cancer.